Month: July 2012
Tech in NH hepatitis C case worked in Mich., Md.
A traveling hospital technician accused of causing a hepatitis C outbreak in New Hampshire previously worked in Maryland and Michigan health care facilities, officials said Friday.
FDA OKs Onyx’s Kyprolis for multiple myeloma
WASHINGTON (Reuters) – U.S. drug regulators approved Onyx Pharmaceuticals Inc’s Kyprolis for people with a type of blood cancer that has failed to respond to other medicines. The U.S. Food and Drug Administration said on Friday the intravenous drug was approved for treating multiple myeloma in people who have tried at least two other medicines, including Takeda Pharmaceutical Co Ltd’s Velcade and Celgene Corp’s Revlimid or Thalomid. Multiple myeloma, a type of cancer that affects the plasma cells in bone marrow, is relatively rare in the United States but often deadly. …
FDA approves Novartis drug Afinitor for breast cancer
(Reuters) – The U.S. Food and Drug Administration on Friday approved Novartis AG drug Afinitor to treat women with a certain type of breast cancer. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The European Medicines Agency in June also endorsed Afinitor as a breast cancer treatment. …
Western fast food tied to heart risks in Asia
NEW YORK (Reuters Health) – Even relatively clean-living Singaporeans who regularly eat burgers, fries and other staples of U.S.-style fast food are at raised risk of diabetes and significantly more likely than peers to die of heart disease, according to a new study. With globalization, fast food – widely regarded as nutritionally poor – has become commonplace in East and Southeast Asia. But there’s been little research into the effects of western junk food on the health of non-western populations, especially those transitioning to more-prosperous lifestyles. …
Afinitor Approved for Advanced Breast Cancer
FRIDAY, July 20 (HealthDay News) — Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday.
Health Highlights: July 20, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
HPV Might Raise Risk of Form of Skin Cancer
FRIDAY, July 20 (HealthDay News) — Infection with cutaneous human papillomavirus (HPV) is linked to a type of skin cancer known as squamous cell carcinoma, according to a new study.
Vitamin D May Delay Deterioration of Smokers’ Lungs: Study
Talk to Your Kids About the Colorado Killings
FRIDAY, July 20 (HealthDay News) — As word spread Friday that a heavily armed man had shot up a suburban Denver movie theater crowded with families and children for a midnight showing of the new Batman movie, mental health experts offered guidance on how to cope with the tragedy.
FDA Gives Nod to New Breast Cancer Drug
FRIDAY, July 20 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breast cancer.
Many Medicaid Patients Skip Drugs That Could Prevent Heart Trouble
FRIDAY, July 20 (HealthDay News) — Many Medicaid recipients with chronic health conditions that can lead to heart disease — diabetes, high blood pressure and high cholesterol — do not take their prescribed medications, a new study has found.